Insider Transactions in Q2 2023 at Owens & Minor Inc (OMI)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2023
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
BUY
Grant, award, or other acquisition
|
Direct |
554
+0.3%
|
$8,864
$16.23 P/Share
|
|
Jun 30
2023
|
Edward A Pesicka President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
923
+0.13%
|
$14,768
$16.23 P/Share
|
|
Jun 30
2023
|
Michael Wayne Lowry SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
739
+0.9%
|
$11,824
$16.23 P/Share
|
|
Jun 30
2023
|
Snehashish Sarkar EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
739
+1.57%
|
$11,824
$16.23 P/Share
|
|
Jun 30
2023
|
Heath H Galloway EVP,General Counsel & CorpSecy |
BUY
Grant, award, or other acquisition
|
Direct |
56
+0.13%
|
$896
$16.23 P/Share
|
|
Jun 16
2023
|
Edward A Pesicka President & CEO |
SELL
Open market or private sale
|
Direct |
38,780
-1.75%
|
$736,820
$19.28 P/Share
|
|
Jun 15
2023
|
Edward A Pesicka President & CEO |
SELL
Open market or private sale
|
Direct |
38,780
-1.66%
|
$736,820
$19.24 P/Share
|
|
Jun 09
2023
|
Edward A Pesicka President & CEO |
SELL
Open market or private sale
|
Direct |
118,928
-13.14%
|
$2,378,560
$20.79 P/Share
|
|
Jun 08
2023
|
Edward A Pesicka President & CEO |
SELL
Open market or private sale
|
Direct |
118,928
-11.62%
|
$2,497,488
$21.19 P/Share
|
|
Jun 07
2023
|
Edward A Pesicka President & CEO |
SELL
Open market or private sale
|
Direct |
118,927
-10.41%
|
$2,497,467
$21.56 P/Share
|
|
Jun 06
2023
|
Edward A Pesicka President & CEO |
SELL
Open market or private sale
|
Direct |
118,927
-9.43%
|
$2,378,540
$20.86 P/Share
|
|
Jun 06
2023
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Open market or private sale
|
Direct |
10,000
-11.07%
|
$210,000
$21.11 P/Share
|
|
May 19
2023
|
Andrew G Long EVP, CEO P&HS |
SELL
Bona fide gift
|
Direct |
115,555
-34.25%
|
-
|
|
May 17
2023
|
Heath H Galloway EVP,General Counsel & CorpSecy |
BUY
Grant, award, or other acquisition
|
Direct |
17,794
+29.8%
|
-
|
|
May 15
2023
|
Alexander J Bruni EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,641
-2.93%
|
$29,538
$18.73 P/Share
|
|
May 15
2023
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
8,266
-2.39%
|
$148,788
$18.73 P/Share
|
|
May 15
2023
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,407
-1.34%
|
$25,326
$18.73 P/Share
|
|
May 15
2023
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
928
-1.02%
|
$16,704
$18.73 P/Share
|
|
May 15
2023
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,555
-1.45%
|
$333,990
$18.73 P/Share
|
|
May 15
2023
|
Nicholas J Pace EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,947
-1.82%
|
$89,046
$18.73 P/Share
|
|
May 15
2023
|
Daniel J Starck EVP, Business Excellence |
SELL
Payment of exercise price or tax liability
|
Direct |
2,139
-2.88%
|
$38,502
$18.73 P/Share
|
|
May 15
2023
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
6,998
-3.68%
|
$125,964
$18.73 P/Share
|
|
May 12
2023
|
Teresa L. Kline Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+39.93%
|
-
|
|
May 12
2023
|
Carissa Rollins Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+40.31%
|
-
|
|
May 12
2023
|
Rita Johnson Mills Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+39.93%
|
-
|
|
May 12
2023
|
Stephen W Klemash Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+32.99%
|
-
|
|
May 12
2023
|
Kenneth Gardner Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+38.61%
|
-
|
|
May 12
2023
|
Robert J Henkel Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+20.01%
|
-
|
|
May 12
2023
|
Mark A Beck Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,344
+50.0%
|
-
|
|
May 11
2023
|
Alexander J Bruni EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,219
-5.43%
|
$57,942
$18.39 P/Share
|
|
May 11
2023
|
Perry A Bernocchi EVP, CEO,. Patient Direct |
SELL
Payment of exercise price or tax liability
|
Direct |
6,583
-3.35%
|
$118,494
$18.39 P/Share
|
|
May 11
2023
|
Edward A Pesicka President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,163
-3.41%
|
$812,934
$18.39 P/Share
|
|
May 11
2023
|
Nicholas J Pace EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,186
-2.57%
|
$129,348
$18.39 P/Share
|
|
May 11
2023
|
Michael Wayne Lowry SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,453
-1.57%
|
$26,154
$18.39 P/Share
|
|
May 11
2023
|
Andrew G Long EVP, CEO P&HS |
SELL
Payment of exercise price or tax liability
|
Direct |
7,186
-2.04%
|
$129,348
$18.39 P/Share
|
|
May 11
2023
|
Jonathan A Leon EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,713
-1.61%
|
$30,834
$18.39 P/Share
|